| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $99.1M | — | -26.2% |
| Cost of Revenue | $94.8M | — | +3.9% |
| Gross Profit | $4.3M | — | -90.0% |
| R&D Expense | $28.4M | — | -3.8% |
| SG&A Expense | $9.9M | — | -41.6% |
| Operating Income | -$57.2M | — | -26.6% |
| Pre-tax Income | -$79.0M | — | -75.3% |
| Income Tax | $1.8M | — | +11.7% |
| Net Income | -$80.8M | — | -73.0% |
| EPS (Diluted) | -$0.50 | — | -66.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $40.7M | -18.0% | -41.5% |
| Accounts Receivable | $61.9M | -33.9% | -19.3% |
| Inventory | $72.2M | -7.9% | -25.0% |
| Current Assets | $207.3M | -17.9% | -25.7% |
| Total Assets | $381.4M | -10.9% | -17.5% |
| Current Liabilities | $356.9M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$36.6M | — | +36.0% |
| Capital Expenditures | $1.0M | — | -20.1% |
| Investing Cash Flow | -$1.0M | — | +20.1% |
| Financing Cash Flow | $28.8M | — | +15.8% |
| Free Cash Flow | -$37.7M | — | +35.6% |
| +12.6% |
| Long-term Debt | $0 | -100.0% | — |
| Total Liabilities | $383.2M | +9.0% | +8.7% |
| Stockholders' Equity | -$1.9M | -102.4% | -101.7% |